Title:
【発明の名称】アンパカインおよび神経遮断薬を用いる精神分裂病の処置
Document Type and Number:
Japanese Patent JP2001520978
Kind Code:
A
Abstract:
This invention relates to treatment of schizophrenia and related psychotic disorders, including enhancement of receptor functioning in synapses in brain networks responsible for higher order behaviors. In a particular aspect, the invention relates to methods for the use of AMPA receptor up-modulators in conjunction with antipsychotics for the treatment of schizophrenia. Kits containing the compositions in appropriate form for administration are also provided.
Inventors:
Johnson, Stephen A.
Rogers, Gary A.
Lynch, Gary S.
Rogers, Gary A.
Lynch, Gary S.
Application Number:
JP2000517599A
Publication Date:
November 06, 2001
Filing Date:
October 26, 1998
Export Citation:
Assignee:
Cortex Pharmaceuticals, Inc.
The Regents of the University of California
The Regents of the University of California
International Classes:
C07D295/18; A61K31/357; A61K31/36; A61K31/38; A61K31/4025; A61K31/443; A61K31/445; A61K31/4453; A61K31/4525; A61K31/453; A61K31/454; A61K31/4545; A61K31/496; A61K31/498; A61K31/519; A61K31/535; A61K31/5355; A61K31/5365; A61K31/5375; A61K31/5377; A61K31/541; A61K31/5415; A61K31/55; A61K31/5513; A61K31/554; A61K45/00; A61K45/06; A61P25/18; C07D211/70; C07D235/08; C07D241/42; C07D263/56; C07D271/12; C07D285/26; C07D317/46; C07D317/54; C07D317/60; C07D405/06; C07D405/12; C07D413/06; C07D498/04; C07D498/14; (IPC1-7): A61K45/00; A61K31/36; A61K31/38; A61K31/4025; A61K31/445; A61K31/4453; A61K31/4525; A61K31/453; A61K31/454; A61K31/4545; A61K31/496; A61K31/498; A61K31/519; A61K31/535; A61K31/5365; A61K31/5377; A61K31/5415; A61K31/55; A61K31/5513; A61K31/554; A61P25/18; C07D211/70; C07D235/08; C07D263/56; C07D271/12; C07D498/14
Attorney, Agent or Firm:
Takeshi Oshio